Platelet-released supernatant increases matrix metalloproteinase-2 production, migration, proliferation, and tube formation of human umbilical vascular endothelial cells

Journal of Periodontology

Volumn 75, Issue 9, 2004, Pages 1255-1261

  Kandler, Barbara ^a   Fischer, Michael B ^a   Watzek, Georg ^a,b   Gruber, Reinhard ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Angiograms; Blood vessels; Bone regeneration; Cells, endothelial; Mitogen activated protein kinases; Plasma physiology; Platelet activation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; TRITIUM;

ANGIOGENESIS; ARTICLE; ASSAY; BASEMENT MEMBRANE; BONE REGENERATION; CAPILLARY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DATA ANALYSIS; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; INCUBATION TIME; MITOGENESIS; SIGNAL TRANSDUCTION; SUPERNATANT; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; UMBILICAL CORD; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ZYMOGRAPHY;

BASEMENT MEMBRANE; BLOOD PLATELETS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CAPILLARIES; CELL EXTRACTS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 2; PLATELET ACTIVATION; SECRETORY VESICLES; THYMIDINE;

EID: 7044274748     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.9.1255     Document Type: Article

References (48)

1. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
2. Page RC. The etiology and pathogenesis of periodontitis. Compend Contin Educ Dent 2001;23:11-14.
3. Roos-Jansaker AM, Renvert S, Egelberg J. Treatment of peri-implant infections: A literature review. J Clin Periodontol 2003;30:467-485.
4. Caffesse RG, de la Rosa M, Mota LF. Regeneration of soft and hard tissue periodontal defects. Am J Dent 2002;15:339-345.
5. Froum SJ, Gomez C, Breault MR. Current concepts of periodontal regeneration. A review of the literature. N Y State Dent J 2002;68:14-22.
6. Haas R, Baron M, Donath K, Zechner W, Watzek G. Porous hydroxyapatite for grafting the maxillary sinus: A comparative histomorphometric study in sheep. Int J Oral Maxillofac Implants 2002;17:337-346.
7. Schenk RK, Buser D. Osseointegration: A reality. Periodontol 2000 1998;17:22-35.
8. Bolander ME. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992;200:165-170.
9. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res 1999;14:1805-1815.
10. Schliephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002; 31:469-484.
11. Street J, Winter D, Wang JH, Wakai A, McGuinness A, Redmond HP. Is human fracture hematoma inherently angiogenic? Clin Orthop 2000;378:224-237.
12. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-646.
13. Petrungaro PS. Treatment of the infected implant site using platelet-rich plasma. Compend Contin Educ Dent 2002;23:363-366.
14. Carlson NE, Roach RB Jr. Platelet-rich plasma: Clinical applications in dentistry. J Am Dent Assoc 2002;133: 1383-1386.
15. Soffer E, Ouhayoun JP, Anagnostou F. Fibrin sealants and platelet preparations in bone and periodontal healing platelet-rich plasma: Clinical applications in dentistry. J Clin Periodontol 2003;30:746-751.
16. Gruber R, Karreth F, Frommlet F, Fischer MB, Watzek G. Platelets are mitogenic for periosteum-derived cells. J Orthop Res 2003;21:941-948.
17. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: Involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002;13:529-535.
18. Gruber R, Karreth F, Fischer MB, Watzek G. Platelet-released supernatant stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. Bone 2002;30:726-732.
19. Oprea WE, Karp JM, Hosseini MM, Davies JE. Effect of platelet release on bone cell migration and recruitment in vitro. J Craniofac Surg 2003;14:292-300.
20. Kawase T, Okuda K, Wolff LF, Yoshie H. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 2003;74:858-864.
21. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
22. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001;49:507-521.
23. Risau W. Mechanisms of angiogenesis. Nature 1997;386: 671-674.
24. Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001;33:960-970.
25. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001;21:1104-1117.
26. May AE, Kalsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M. Engagement of glycoprotein IIb/IIIa (alpha (IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002;106:2111-2117.
27. English D, Welch Z, Kovala AT, et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 2000;14:2255-2265.
28. Marcondes S, Lafay M, Brohard-Bohn B, de Nucci G, Rendu F. Platelets induce human umbilical vein endothelial cell proliferation through P-selectin. Life Sci 2000;66: 1817-1826.
29. Pipili-Synetos E, Papadimitriou E, Maragoudakis ME. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 1998;125: 1252-1257.
30. Pintucci G, Froum S, Pinnell J, Mignatti P, Rafii S, Green D. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 and vascular endothelial growth factor. Thromb Haemost 2002;88:834-842.
31. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998;74:49-139.
32. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein kinase pathways: Regulation and physiological functions. Endocr Rev 2001;22:153-183.
33. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature 2001;410:37-40.
34. Werle M, Schmal U, Hanna K, Kreuzer J. MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc Res 2002;56:284-292.
35. Secchiero P, Gonelli A, Carnevale E, et al. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 2003;107:2250-2256.
36. Shono T, Kanetake H, Kanda S. The role of mitogen-activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells. Exp Cell Res 2001;264:275-283.
37. Miura SI, Fujino M, Matsuo Y, et al. High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:802-808.
38. Moog R, Muller N. White cell reduction during platelet-pheresis: A comparison of three blood cell separators. Transfusion 1999;39:572-577.
39. Rebulla P. Revisitation of the clinical indications for the transfusion of platelet concentrates. Rev Clin Exp Hematol 2001;5:288-310.
40. Weibrich G, Kleis WK, Hafner G, Hitzler WE, Wagner W. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res 2003;14:357-362.
41. Weibrich G, Kleis WK, Buch R, Hitzler WE, Hafner G. The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Clin Oral Implants Res 2003;14:233-239.
42. Zimmermann R, Arnold D, Strasser E, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003;85:283-289.
43. Zimmermann R, Jakubietz R, Jakubietz M, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001;41:1217-1224.
44. Daly ME, Makris A, Reed M, Lewis CE. Hemostatic regulators of tumor angiogenesis: A source of antiangiogenic agents for cancer treatment? J Natl Cancer Inst 2003;95: 1660-1673.
45. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002;30:97-102.
46. Scheubel RJ, Zorn H, Silber RE, et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003;42:2073-2080.
47. Lacoste E, Martineau I, Gagnon G. Platelet concentrates: Effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J Periodontol 2003; 74:1498-1507.
48. Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction: A histological and histomorphometric study on the use of autogenous scaffolds, particulate cortico-cancellous bone grafts and platelet rich plasma in goats. Int J Oral Maxillofac Surg 2004;33:48-55.